Belite Bio, Inc (BLTE) Free cash flow 2021–2025
Belite Bio, Inc (BLTE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$37.1MFY2025 · since FY2021: -$7.5M → -$37.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.1M | -26.3% |
| FY2024 | -$29.4M | +1.8% |
| FY2023 | -$29.9M | -152.3% |
| FY2022 | -$11.9M | -57.0% |
| FY2021 | -$7.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice